Schultheis_1997_Pacing.Clin.Electrophysiol_20_1369

Reference

Title : High dose neostigmine treatment of malignant sinus tachycardia - Schultheis_1997_Pacing.Clin.Electrophysiol_20_1369
Author(s) : Schultheis LW , Balser JR , Calkins H , Robertson S , Weiss JL , Sussman M , Stuart RS
Ref : Pacing Clin Electrophysiol , 20 :1369 , 1997
Abstract :

Sinus tachycardia caused by circulating catecholamines in the setting of congestive heart failure may impair systemic perfusion because of decreased diastolic filling time. We report the case of a patient with Wolff-Parkinson-White syndrome with angina and cardiogenic shock who improved dramatically following administration of neostigmine. Cardiac output, blood pressure, and stroke volume increased as heart rate was reduced. A previous attempt at heart rate control, in the same patient, using a low dose beta-antagonist, precipitated hemodynamic collapse. The remarkable recovery of our patient suggests that acetylcholinesterase inhibitors may warrant further investigation in patients with severe sinus tachycardia.

PubMedSearch : Schultheis_1997_Pacing.Clin.Electrophysiol_20_1369
PubMedID: 9170142

Related information

Citations formats

Schultheis LW, Balser JR, Calkins H, Robertson S, Weiss JL, Sussman M, Stuart RS (1997)
High dose neostigmine treatment of malignant sinus tachycardia
Pacing Clin Electrophysiol 20 :1369

Schultheis LW, Balser JR, Calkins H, Robertson S, Weiss JL, Sussman M, Stuart RS (1997)
Pacing Clin Electrophysiol 20 :1369